WATSON 746 (Clonazepam 0.5 mg)
Pill imprint WATSON 746 has been identified as Clonazepam 0.5 mg.
Clonazepam is used in the treatment of panic disorder; bipolar disorder; seizure prevention; periodic limb movement disorder; sleep paralysis (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.5 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for WATSON 746 (Clonazepam 0.5 mg)
- Imprint:
-
WATSON 746
- Strength:
- 0.5 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Benzodiazepine anticonvulsants
Benzodiazepines - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0746
- Inactive Ingredients:
- docusate sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium benzoate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55289-0599 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More resources
Clonazepam is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
